Asterias Biotherapeutics Inc. (NYSEMKT:AST) will post its Q216 quarterly earnings results on Monday, August 15th. Analysts expect Asterias Biotherapeutics to post earnings of ($0.19) per share and revenue of $1.14 million for the quarter. Asterias Biotherapeutics (NYSEMKT:AST) last posted its quarterly earnings results on Monday, May 16th. The company reported ($0.27) earnings per share for […]
